topic

P11.01 Oncological outcomes of laparoscopic versus open radical total gastrectomy for upper-middle gastric cancer after neoadjuvant chemotherapy
S Li-LI, G You-xin, Z Zhi-wei

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A29; DOI: 10.1136/jitc-2024-ITOC10.53
09.03 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (INHALE)
K Leuchte, V Luu, S Salo, A Vinther, P Thor Straten, G Olofsson

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A3; DOI: 10.1136/jitc-2024-ITOC10.5
P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML
S Stock, T Strzalkowski, A Gottschlich, L Rohrbacher, L Fertig, VD Menkhoff, M Surowka, P Bruenker, D Darowski, S Endres, M von Bergwelt-Baildon, M Subklewe, C Klein, S Kobold

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A30-A31; DOI: 10.1136/jitc-2024-ITOC10.56
P12.01 Utilizing radiation to improve adoptive cell therapy with tumor infiltrating lymphocytes
N Obertopp, A Thomas, J Ali, J Blauvelt, A Hall, H Enderling, S Pilon-Thomas

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A30; DOI: 10.1136/jitc-2024-ITOC10.55
P12.03 Heterotypic CD8 T cell clusters isolated from clinical samples are distinct and enriched for antitumor activity
S Ibáñez Molero, J Veldman, JJH Traets, A George, K Hoefakker, S Pack, L Tas, P Alóndiga-Mérida, B van den Broek, R Harkes, M Nieuwland, M van Baalen, E Mul, S Tol, JBAG Haanen, WJv Houdt, DS Peeper

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A31-A32; DOI: 10.1136/jitc-2024-ITOC10.57
P12.04 Adherence to clinical guidelines for managing febrile neutropenia inpatients undergoing hematopoietic stem cell transplantation: are weinclined to follow the recommendations of IDSA and NCCN in LMIC?
K Ali

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A32-A33; DOI: 10.1136/jitc-2024-ITOC10.58
P12.06 GLP-compliant validation of a FluoroSpot assay to monitor tumor neoantigen vaccinations in preclinical mouse models
A Mauthe, R Villar-Hernández, M Springer, R Preyer, M Gutekunst

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A33-A34; DOI: 10.1136/jitc-2024-ITOC10.60
P12.05 Cellular biosensors to study protein interactions relevant to immunotherapy
MA Funk, J Leitner, C Battin, S Gumpelmair, S Theurich, P Steinberger

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A33; DOI: 10.1136/jitc-2024-ITOC10.59
P12.07 AI-enhanced quantitative assessment of T cell cytotoxicity using label-free live-cell imaging on micro-pattern for high-throughput investigation of T cell quality and moderation by tumor microenvironment
J Cao, W Xu, AJ Fischbeck, AS Herbstritt, S Prins, J Rädler, E Noessner, M Seiwald, D Rüdiger

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A34-A35; DOI: 10.1136/jitc-2024-ITOC10.61
P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins
F Gsottberger, K Wendland, S Petkovic, L Nitschke, A Mackensen, F Müller

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A35; DOI: 10.1136/jitc-2024-ITOC10.62

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages